home All News open_in_new Full Article

Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

To release full third quarter 2025 financial results on November 13th; conference call to follow TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today announced preliminary unaudited revenues […]


today 8 h. ago attach_file Sport

attach_file Sport
attach_file Other
attach_file Other
attach_file Economics
attach_file Science
attach_file Sport
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 4205122174
Add Watch Country

arrow_drop_down